RxDoctor Payments Data

Susan Dick, MD

Family Medicine · Neptune, NJNPI 1669442935

Payments from drug & device makers

$208in general payments, 2019–2025

Across 14 payments — averaging $14.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$47
  • AstraZeneca$26
  • Kowa Pharmaceuticals America, Inc.$25
  • Boehringer Ingelheim$24
  • Exact Sciences$23
  • Johnson & Johnson$23
  • plus $39 from 3 others

What the payments were for

  • Food & beverage$208100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$208 in reported general payments places this provider in the 35th percentile of 2,084 family medicine providers in New Jersey.

See all family medicine providers in New Jersey

Medicare billing

Part B allowed, 2024
$182,292
Medicare patients
199
Services billed
1,696

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban47$39,023
FarxigaDapagliflozin Propanediol19$16,704
XareltoRivaroxaban23$14,236
TradjentaLinagliptin16$12,503
Breo ElliptaFluticasone/Vilanterol13$7,262
OxycontinOxycodone Hcl12$6,967
SynthroidLevothyroxine Sodium71$6,649
Arnuity ElliptaFluticasone Furoate23$4,621
Albuterol Sulfate HfaAlbuterol Sulfate70$3,262
Lantus SolostarInsulin Glargine,hum.Rec.Anlog17$2,676
Fluticasone-SalmeterolFluticasone Propion/Salmeterol14$2,519
Levothyroxine Sodium182$1,869
Pantoprazole Sodium124$1,748
Olmesartan-HydrochlorothiazideOlmesartan/Hydrochlorothiazide25$1,379
Valsartan-HydrochlorothiazideValsartan/Hydrochlorothiazide13$1,345

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AstraZenecaFarxiga$26$16,70419 claims
Johnson & JohnsonXarelto$23$14,23623 claims
Boehringer IngelheimTradjenta$24$12,50316 claims
Teva Pharmaceuticals USA, Inc.Acyclovir$13$60011 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 35th percentile of 2,084 family medicine providers in New Jersey.

Other family medicine in Neptune

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →